Cargando…
Cancer: A disease at the crossroads of trade‐offs
Central to evolutionary theory is the idea that living organisms face phenotypic and/or genetic trade‐offs when allocating resources to competing life‐history demands, such as growth, survival, and reproduction. These trade‐offs are increasingly considered to be crucial to further our understanding...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322410/ https://www.ncbi.nlm.nih.gov/pubmed/28250806 http://dx.doi.org/10.1111/eva.12444 |
_version_ | 1782509841699307520 |
---|---|
author | Jacqueline, Camille Biro, Peter A. Beckmann, Christa Moller, Anders Pape Renaud, François Sorci, Gabriele Tasiemski, Aurélie Ujvari, Beata Thomas, Frédéric |
author_facet | Jacqueline, Camille Biro, Peter A. Beckmann, Christa Moller, Anders Pape Renaud, François Sorci, Gabriele Tasiemski, Aurélie Ujvari, Beata Thomas, Frédéric |
author_sort | Jacqueline, Camille |
collection | PubMed |
description | Central to evolutionary theory is the idea that living organisms face phenotypic and/or genetic trade‐offs when allocating resources to competing life‐history demands, such as growth, survival, and reproduction. These trade‐offs are increasingly considered to be crucial to further our understanding of cancer. First, evidences suggest that neoplastic cells, as any living entities subject to natural selection, are governed by trade‐offs such as between survival and proliferation. Second, selection might also have shaped trade‐offs at the organismal level, especially regarding protective mechanisms against cancer. Cancer can also emerge as a consequence of additional trade‐offs in organisms (e.g., eco‐immunological trade‐offs). Here, we review the wide range of trade‐offs that occur at different scales and their relevance for understanding cancer dynamics. We also discuss how acknowledging these phenomena, in light of human evolutionary history, may suggest new guidelines for preventive and therapeutic strategies. |
format | Online Article Text |
id | pubmed-5322410 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53224102017-03-01 Cancer: A disease at the crossroads of trade‐offs Jacqueline, Camille Biro, Peter A. Beckmann, Christa Moller, Anders Pape Renaud, François Sorci, Gabriele Tasiemski, Aurélie Ujvari, Beata Thomas, Frédéric Evol Appl Reviews and Syntheses Central to evolutionary theory is the idea that living organisms face phenotypic and/or genetic trade‐offs when allocating resources to competing life‐history demands, such as growth, survival, and reproduction. These trade‐offs are increasingly considered to be crucial to further our understanding of cancer. First, evidences suggest that neoplastic cells, as any living entities subject to natural selection, are governed by trade‐offs such as between survival and proliferation. Second, selection might also have shaped trade‐offs at the organismal level, especially regarding protective mechanisms against cancer. Cancer can also emerge as a consequence of additional trade‐offs in organisms (e.g., eco‐immunological trade‐offs). Here, we review the wide range of trade‐offs that occur at different scales and their relevance for understanding cancer dynamics. We also discuss how acknowledging these phenomena, in light of human evolutionary history, may suggest new guidelines for preventive and therapeutic strategies. John Wiley and Sons Inc. 2016-12-26 /pmc/articles/PMC5322410/ /pubmed/28250806 http://dx.doi.org/10.1111/eva.12444 Text en © 2016 The Authors. Evolutionary Applications published by John Wiley & Sons Ltd This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews and Syntheses Jacqueline, Camille Biro, Peter A. Beckmann, Christa Moller, Anders Pape Renaud, François Sorci, Gabriele Tasiemski, Aurélie Ujvari, Beata Thomas, Frédéric Cancer: A disease at the crossroads of trade‐offs |
title | Cancer: A disease at the crossroads of trade‐offs |
title_full | Cancer: A disease at the crossroads of trade‐offs |
title_fullStr | Cancer: A disease at the crossroads of trade‐offs |
title_full_unstemmed | Cancer: A disease at the crossroads of trade‐offs |
title_short | Cancer: A disease at the crossroads of trade‐offs |
title_sort | cancer: a disease at the crossroads of trade‐offs |
topic | Reviews and Syntheses |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322410/ https://www.ncbi.nlm.nih.gov/pubmed/28250806 http://dx.doi.org/10.1111/eva.12444 |
work_keys_str_mv | AT jacquelinecamille canceradiseaseatthecrossroadsoftradeoffs AT biropetera canceradiseaseatthecrossroadsoftradeoffs AT beckmannchrista canceradiseaseatthecrossroadsoftradeoffs AT molleranderspape canceradiseaseatthecrossroadsoftradeoffs AT renaudfrancois canceradiseaseatthecrossroadsoftradeoffs AT sorcigabriele canceradiseaseatthecrossroadsoftradeoffs AT tasiemskiaurelie canceradiseaseatthecrossroadsoftradeoffs AT ujvaribeata canceradiseaseatthecrossroadsoftradeoffs AT thomasfrederic canceradiseaseatthecrossroadsoftradeoffs |